Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously;Traitement de la carence martiale en prédialyse par l'administration intraveineuse de doses élevées de fer dextran de bas poids moléculaire

Nephrologie et Therapeutique

Volumn 8, Issue 1, 2012, Pages 41-45

  Fievet, Patrick ^a   Coppin, Mathilde ^a   Brazier, Franois ^a   Lefvre, Magali ^a   Stephan, Robin ^a   Demontis, Renato ^a  

^a CENTRE HOSPITALIER LAENNEC   (France)

Author keywords

Anaemia; Chronic kidney disease; intravenous iron; Iron deficiency; Predialysis

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON DEXTRAN; LOW MOLECULAR WEIGHT IRON DEXTRAN; TRANSFERRIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ARTHRALGIA; ARTICLE; BIOACCUMULATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; KIDNEY FUNCTION; MYALGIA; RETICULOENDOTHELIAL SYSTEM; RISK ASSESSMENT; SINGLE DRUG DOSE; TRANSFERRIN BLOOD LEVEL; VENOUS INFLAMMATORY REACTION;

AGED; DEFICIENCY DISEASES; FEMALE; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; IRON-DEXTRAN COMPLEX; MALE; MOLECULAR WEIGHT; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84857238208     PISSN: 17697255     EISSN: 18729177     Source Type: Journal    
DOI: 10.1016/j.nephro.2011.04.005     Document Type: Article

References (31)

1. S. Fishbane, S. Pollack, H.I. Feldman, and M.M. Joffe Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004 Clin J Am Soc Nephrol 4 2009 57 61
2. C.Y. Hsu, C.E. McCulloch, and G.C. Curhan Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third National Health and Nutrition Examination Survey J Am Soc Nephrol 13 2002 504 510 (Pubitemid 34106294)
3. J. Rossert, C. Gassmann-Mayer, D. Frei, and W. McClellan Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients Nephrol Dial Transplant 22 2007 794 800 (Pubitemid 46351687)
4. L.A. Szczech, H.X. Barnhart, J.K. Inrig, D.N. Reddan, S. Sapp, and R.M. Califf Secondary analysis of the CHOIR trial epoetin α dose and achieved haemoglobin outcomes Kidney Int 74 2008 791 798
5. S.D. Salomon, H. Uno, E.F. Lewis, K.U. Eckardt, J. Lin, and E.A. Burdmann Erythropoietic response and outcomes in kidney disease and type 2 diabetes N Engl J Med 363 2010 1146 1155
6. B. Rozen-Zvi, A. Gafter-Gvili, M. Paul, L. Leibovici, O. Shpilberg, and U. Gafter Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis Am J Kidney Dis 52 2008 897 906
7. M. Auerbach, J. Winchester, A. Wahab, K. Richards, M. McGinley, and F. Hall A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients Am J Kidney Dis 31 1998 81 86 (Pubitemid 28116687)
8. A.M. Ganzoni Eisen-sextran intravenous: therapeutische und experimentelle Môglichkeiten Schweiz Med Wschr 100 1970 301 303
9. A.M. Ganzoni, G. Tondung, and K. Rhymer Orale einsenmedikation Vertraglichkert von eisensulfat und eisensulfat + bernsteinsaure. Einfluss auf die hamoglobinkonzentration gesunder Deutsche Medizinische Wochenschrift 99 1974 1175 1178
10. G. Chandler, J. Harchowal, and I.C. Macdougall Intravenous iron sucrose: establishing a safe dose Am J Kidney Dis 38 2001 988 991 (Pubitemid 33022176)
11. A. Blaustein, M.H. Schwenk, J. Chattopadhyay, and M.M. Avram Recent experience with highdose intravenous iron administration Kidney Int 70 2006 S26 S29
12. E. Ranfaing Treatment of the martial deficiencies: preparations available in France Néphrologie & Thérapeutique 2 2006 S337 S340
13. D.S. Silverberg, A. Iaina, G. Peer, E. Kaplan, B.A. Levi, and N. Frank Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis Am J Kidney Dis 27 1996 234 238 (Pubitemid 26055136)
14. D. Bhowmik, G. Modi, D. Ray, S. Gupta, S.K. Agarwal, and S.C. Tiwari Total dose iron infusion: safety and efficacy in predialysis patients Ren Fail 22 2000 39 43 (Pubitemid 30130934)
15. S. Anuradha, N.P. Singh, and S.K. Argawal Total dose infusion iron dextran therapy in predialysis chronic renal failure Ren Fail 24 2002 307 313 (Pubitemid 34839951)
16. D.B. Van Wyck, M. Roppolo, C.O. Martinez, R.M. Mazey, and S. McMurray A randomized, controlled trial comparing intravenous iron sucrose to oral iron in anemic patients with non dialysis-dependent CKD Kidney Int 68 2005 2846 2856 (Pubitemid 43251032)
17. R. Agarwal, A.R. Rizkala, B. Bastani, M.O. Kaskas, D.J. Leehey, and A. Besarab A randomized controlled trial of oral versus intravenous iron in chronic kidney disease Am J Nephrol 26 2006 445 454 (Pubitemid 44971735)
18. L. Gotloib, D. Silverberg, R. Fudin, and A. Shostak Iron deficiency is a common cause of anemia in chronic kidney disease and can be corrected with intravenous iron J Nephrol 19 2006 161 167 (Pubitemid 44420105)
19. G. Mircescu, L. Garneata, C. Capusa, and N. Ursea Intravenous supplementation for the treatment of anaemia in predialyzed chronic renal failure patients Nephrol Dial Transplant 21 2006 120 124 (Pubitemid 43057119)
20. B.S. Spinowitz, A.T. Kausz, J. Baptista, S.D. Noble, R. Sothinathan, and M.V. Bernardo Ferumoxytol for treating iron deficiency anemia in CKD J Am Soc Nephrol 19 2008 1599 1605
21. S. Tagboto, L. Cropper, S. Mostafa, J. Turner, G. Bailey, and K. Pugh-Clarke Intravenous iron in chronic kidney disease; haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin J Renal Care 34 2008 112 115
22. S. Tagboto, L. Cropper, J. Turner, and K. Pugh-Clarke The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject®) on anaemia in a predialysis population of chronic kidney disease patients J Renal Care 35 2009 18 23
23. W.Y. Qunibi, C. Martinez, M. Smith, J. Benjamin, A. Mangione, and S.D. Roger A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis- dependent chronic kidney disease patients Nephrol Dial Tranplant 26 2011 1599 1607
24. G.M. Chertow, P.D. Mason, O. Vaage-Nilsen, and J. Ahlmen Update on adverse drug events associated with parenteral iron Nephrol Dial Tranplant 21 2006 378 382 (Pubitemid 43159991)
25. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006;47:S11-145.
26. D.R. Ashby, D.P. Gale, M. Busbridge, K.G. Murphy, N.D. Duncan, and T.D. Cairns Plasma hepcidin levels are elevated but responsive to EPO therapy in renal disease Kidney Int 75 2009 976 981
27. C.P. Smith, and F. Thevenod Iron transport and the kidney Biochim Biophys Acta 18 1790 2009 724 730
28. M. Wareing, C.J. Ferguson, R. Green, D. Riccardi, and C.P. Smith In vivo characterization of renal iron transport in the anaesthetized rat J Physiol 524 2000 581 586 (Pubitemid 30229520)
29. N.A. Wolff, W. Liu, R.A. Fenton, W.K. Lee, F. Thévenod, and C.P. Smith Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking J Cell Mol Med 15 2011 209 219
30. R.A. Zager, A.C.M. Johnson, and S.Y. Hanson Parenteral iron nephrotoxicity: potential mechanisms and consequence Kidney Int 66 2004 144 156 (Pubitemid 38870090)
31. R. Agarwall, A.R. Rizkala, M.O. Kaskas, R. Minasian, and J.R. Trout Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease Kidney Int 72 2007 638 642 (Pubitemid 47312801)